Welcome!

News Feed Item

Worldwide Medical Polymer Markets: 2013-2020

NEW YORK, March 19, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Worldwide Medical Polymer Markets: 2013-2020
http://www.reportlinker.com/p01628707/Worldwide-Medical-Polymer-Markets-2013-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Plastic

SUMMARY

NanoMarkets believes that medical polymers represents a major opportunity in the medical materials market over the next few years. Several factors are leading to growth in this market. Perhaps the most obvious is the aging of the population in developed nations is expanding the addressable market for polymer implants. Many polymer implants are specifically intended to assist elder patients.
Opportunity in this market has also expanded because the latest technical developments in medical polymers can fine tune implant capabilities, enable better fits for implants, and increased biocompatibility. Polymer structures can also now substitute for cartilage or enable doctors to grow a patient's tissue for transplants.
At the same time the new legal protections that followed the silicone breast implant debacle have considerably reduced the risk in the medical polymer space. And as a result of all of these factors, the medical polymer business has taken off, with the emergence of new start ups and plenty of M&A activity.

With all that is happening in this space, NanoMarkets is publishing a report that identifies current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising. As with all NanoMarkets reports in the medical materials field, this report includes a granular eight-year forecast and also profiles key suppliers and analyzes the complete supply chain for medical polymers. For the firms covered we discuss their strategies and needs along with their strengths and weaknesses. Finally, the report provides an analysis of the market for medical polymers in various important country-specific markets.

Readers of this report will gain the following:

• An analytical review of polymers used for medical applications, including developing implants, diagnostic systems, and hospital labware.
• Knowledge on current technical and market trends, including general market drivers for improvement in the healthcare sector, polymer production, and evaluation for clinical approval.
• An understanding of key medical products and their future implications.
• A pin-pointed analysis of the changing dynamics of polymer producers.
• Eight–year forecasts based on expected market growth.
• A brief technological road map for understanding industry growth.
• Profiles of major companies operating as manufacturers of medical polymers.
• Insight into important geographical locations pertaining to polymer and healthcare sectors.
• Information on the size of the medical polymer market in developed nations and the fast-growing economies in Asia, such as China and India.
• Details of the regulatory requirements of these countries for producing high-quality, medically approved polymers and their use in various applications.
• Help in making business decisions for venturing into the medical polymer market.
• Descriptive and distinctive graphics, along with concise, tabular analyses of various domains.

Executive Summary
E.1 Opportunities in the Medical Device Market
E.2 Opportunities for the Plastics Industry
E.3 Firms and Strategies to Watch in the Medical Polymer Market
E.3.1 Bayer MaterialScience
E.3.2 Celanese
E.3.3 Dow Corning
E.3.4 Dow Chemical
E.3.5 DSM
E.3.6 DuPont
E.3.7 Eastman Chemical
E.3.8 Evonik
E.3.9 Solvay
E.4 Summary of Eight-Year Forecasts of the Medical Polymer Market

Chapter One: Introduction
1.1 Background to this Report
1.1.1 Boom in Thermoplastic Elastomers (TPES) and Engineered Plastics (Super Specialty Plastics)
1.1.2 Rise of Degradable Polymers
1.1.3 Important Points for Manufacturers
1.2 Scope and Objectives of this Report
1.3 Methodology and Information Sources
1.4 Plan of this Report
Chapter Two: Commercial Trends in Medical Polymers
2.1 Generic Advantages and Disadvantages of Polymers for Medical Applications
2.1.1 Advantages of Polymers in Medical Applications
2.1.2 Disadvantages of Polymers in Medical Applications
2.1.3 Replacement of Metals with Polymers in Medical Devices
2.2 Thermoplastics (PMMA, PLA, PGA, PP, PEEK, Polycarbonates)
2.2.1 Uses of Thermoplastics in Medical Applications
2.2.2 Main Suppliers of Thermoplastics for Medical Applications
2.3 Polyethylene (PE)
2.3.1 Uses of PE in Medical Applications

2.3.2 Main Suppliers of PE for Medical Applications
2.4 Polystyrene
2.4.1 Uses of Polystyrene and Styrenics in Medical Applications
2.4.2 Main Suppliers of PS for Medical Applications
2.5 Polyvinyl Chloride
2.5.1 Uses of PVC in Medical Applications
2.5.2 Main Suppliers of PVC for Medical Applications
2.6 Nylon
2.6.1 Uses of Nylon in Medical Applications
2.6.2 Main Suppliers of Nylon for Medical Applications
2.7 Other Polymers for Medical Applications
2.8 Role of Bioplastics in Medical Applications
2.9 Key Points from this Chapter
Chapter Three: Applications for Medical Polymers
3.1 Pricing and Forecast Assumptions
3.1.1 Explanation of Polymer Pricing
3.1.2 Use of Medical Polymers in Different Applications
3.2 Medical Devices and Implants
3.2.1 Current and Future Use of Polymers
3.2.2 Regenerative Medicine and Orthopedic Implants
3.2.3 Contact Lenses and Lens Implants

3.2.4 Implantable Defibrillators and Related Devices
3.2.5 Breast Implants
3.2.6 Conductive Polymer Neural Implants
3.2.7 Blood Filters
3.2.8 Other Medical Devices Using Polymers
3.3 Eight-Year Forecast of Polymers in Implants by Polymer and Implant Type
3.4 Eight-Year Forecast of Polymers in Non-Implantable Devices by Polymer and Device Type
3.4.1 Diagnostic Systems
3.5 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.5.1 Laboratory and Surgical Accessories and Disposables
3.5.2 Surgical Screws, Nails and Plates
3.5.3 Catheters and Tubing
3.5.4 Surgical Gloves
3.5.5 Sutures and Shunts
3.6 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.7 Summary of Forecasts of Medical Polymers
3.7.1 Summary Forecast of Medical Polymers by Application
3.8 Summary Forecast of Medical Polymers by Polymer Type
3.9 Key Points in this Chapter
Chapter Four: National Markets and Regulatory Factors
4.1 Generic Policy Issues Raised by Polymer Medical Devices
4.1.1 Safety Issues Related to Polymer Devices
4.1.2 Problems of Waste Disposal and Management in Medical Polymer Manufacturing
4.1.3 Healthcare Issues and an Aging Population
4.1.4 Geographical Distribution of the Markets
4.2 The Medical Polymer Market in the United States
4.2.1 Medical Polymers and the Biomaterials Access Assurance Act of 1998
4.2.2 Impact of "Obamacare"

4.2.3 Role and Impact of the FDA
4.2.4 Analysis of the Market for Medical Polymers in the U.S.
4.2.5 Eight-Year Forecasts for Medical Polymers in the U.S.
4.3 The Medical Polymer Market in Europe
4.3.1 Role and Impact of the European Commission and Other Regulatory Authorities in the European Union
4.3.2 National Regulations and Regulatory Agencies Impacting Medical Polymer Markets in the EU
4.3.3 Analysis of the Market for Medical Polymers in Europe
4.3.4 Eight-Year Forecast for Medical Polymers in Europe
4.4 The Medical Polymer Market in Japan
4.4.1 National Laws and Regulations Impacting the Medical Polymer Market in Japan
4.4.2 Analysis of Market for Medical Polymers in Japan
4.4.3 Eight-Year Forecast for Medical Polymers in Japan
4.5 The Medical Polymer Market in China
4.5.1 National Laws and Regulations Impacting the Medical Polymer Market in China
4.5.2 Impact of Chinese Industrial Policy on the Medical Polymer Market
4.5.3 Analysis of the Market for Medical Polymers in China
4.5.4 Eight-Year Forecast for Medical Polymers in China
4.6 The Medical Polymer Market in India
4.6.1 National Laws and Regulations Impacting the Medical Polymer Market in India
4.6.2 Analysis of the Market for Medical Polymers in India
4.6.3 Eight-Year Forecast for Medical Polymers in India
4.7 Other Notable National Markets for Medical Polymers
4.7.1 The Medical Polymer Market in Canada
4.7.2 The Medical Polymer Market in Australia
4.7.3 The Medical Polymer Market in South Korea
4.8 Summary of Eight-Year Forecasts of Medical Polymers by Country
Acronyms and Abbreviations Used In this Report
About the Author

List of Exhibits

Exhibit E-1: Summary Forecast of Medical Polymers by Application ( US$ Millions)
Exhibit 2-1: Important Advantages of Polymers and Their Current Applications
Exhibit 2-2: Thermoplastics - Properties and Uses
Exhibit 2-3: Common Suppliers of Thermoplastics
Exhibit 2-4: Opportunities for Different PE Grades
Exhibit 2-5: Different Suppliers of Polyethylene Products and their Features
Exhibit 2-6: Requirements and Medical Applications for Various Types of PS
Exhibit 2-7: Suppliers Of GPPS, HIPS, and SPS Products for Medical Applications and their Trade Names
Exhibit 2-8: Suppliers and Characteristics of Flexible, Rigid and Semi-rigid Medical Grades of PVC
Exhibit 2-9: Nylon Products and Manufacturers
Exhibit 2-10: Medical Devices and Implants Made from Polyurethanes
Exhibit 2-11: Leading Teflon products, Their Manufacturers, and Application Areas
Exhibit 3-1: Pricing of Polymers and Polymer-Based Medical Products
Exhibit 3-2: Approximate Market Share of Different Polymer Types in Each Application
Exhibit 3-3: Selected Polymeric Orthopedic Products, their Manufacturers and Opportunities
Exhibit 3-4: Approved Breast Implants and their Market Opportunities
Exhibit 3-5: Overview of Important Blood Filters
Exhibit 3-6: Overview of Selected Wound Dressing Materials

Exhibit 3-7: Orthopedic Implants and Regenerative Medicines Forecast
Exhibit 3-8: Forecast of Polymer Use In Lens Implants
Exhibit 3-9: Forecast of Polymer Use in Contact Lenses
Exhibit 3-10: Forecast of Polymer Use in Implantable Defibrillators
Exhibit 3-11: Forecast of Polymer Use In Breast Implants
Exhibit 3-12: Forecast of Conductive Polymer Use In Neural Implants
Exhibit 3-13: Forecast of Polymer Use In Blood Filters
Exhibit 3-14: Forecast of Polymer Use In Other Medical Devices
Exhibit 3-15: Polymers Used in Diagnostic Devices and Their Future Opportunities
Exhibit 3-16: Forecast of Polymer Use In Diagnostic Devices
Exhibit 3-17: Forecast of Polymer Use In Automated Analyzers
Exhibit 3-18: Forecast of Polymer Use In Homecare Diagnostic Devices
Exhibit 3-19: Forecast of Polymer Use In Point-of-Care (POC) Diagnostics
Exhibit 3-20: Overview of Important Polymers for Multiple-Use and Disposable Labware Fabrication
Exhibit 3-21: Leading Labware Manufacturers and Their Brands and Market Potential
Exhibit 3-22: Selected Catheter and Tubing Products
Exhibit 3-23: Surgical Gloves and Their Specifications
Exhibit 3-24: Forecast of Polymer Use In Surgical Screws, Nails and Plates
Exhibit 3-25: Forecast of Polymer Use In Catheters and Tubing
Exhibit 3-26: Forecast of Polymer Use In Surgical Gloves
Exhibit 3-27: Forecast of Polymer Use In Sutures and Shunts
Exhibit 3-28: Summary Forecast of Medical Polymers by Application (US $Millions)
Exhibit 3-29: Summary Forecast by Top Polymer Types (U.S.$ Millions)
Exhibit 4-1: Key Industry Issues, Their Impacts, and Probable Solutions
Exhibit 4-2: Important U.S. Regulations Affecting Medical Polymers
Exhibit 4-3: Key Players in the U.S. Medical Polymer Industry Responding to Major Trends
Exhibit 4-4: Eight-Year Forecast of Medical Polymers in the U.S. (US$ Millions)
Exhibit 4-5: Key EC Regulations and Their Significance
Exhibit 4-6: Recent Technology Developments in Europe
Exhibit 4-7: Eight-Year Forecast for Medical Polymers in Europe (US$ Millions)

Exhibit 4-8: Important Regulations in Japan and Their Impact on the Medical Polymers Market
Exhibit 4-9: Recent Technology Developments in Japan
Exhibit 4-10: Eight-Year Forecast for Medical Polymers in Japan (US $Millions)
Exhibit 4-11: Key Impacts of CFDA Policies and Opportunities for Policy Improvement in China
Exhibit 4-12: Recent Technology Developments in China
Exhibit 4-13: Eight-Year Forecast for Medical Polymers in China (US $Millions)
Exhibit 4-14: Key Regulatory Impacts and Opportunities for Policy Improvement in India
Exhibit 4-15: Recent Technology Developments in India
Exhibit 4-16: Eight-Year Forecast for Medical Polymers in India (US $Millions)
Exhibit 4-17: Regulatory Scenario and Industry Opportunities in Other Markets
Exhibit 4-18: Global Eight-Year Forecast for Medical Polymers Broken Out by Country/Region

To order this report: Worldwide Medical Polymer Markets: 2013-2020
http://www.reportlinker.com/p01628707/Worldwide-Medical-Polymer-Markets-2013-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Plastic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
"We focus on composable infrastructure. Composable infrastructure has been named by companies like Gartner as the evolution of the IT infrastructure where everything is now driven by software," explained Bruno Andrade, CEO and Founder of HTBase, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"Tintri focuses on the Ops side of the DevOps, which basically is pushing more and more of the accessibility of the infrastructure to the developers and trying to get behind the scenes," explained Dhiraj Sehgal of Tintri in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Hardware virtualization and cloud computing allowed us to increase resource utilization and increase our flexibility to respond to business demand. Docker Containers are the next quantum leap - Are they?! Databases always represented an additional set of challenges unique to running workloads requiring a maximum of I/O, network, CPU resources combined with data locality.
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
Artificial intelligence, machine learning, neural networks. We’re in the midst of a wave of excitement around AI such as hasn’t been seen for a few decades. But those previous periods of inflated expectations led to troughs of disappointment. Will this time be different? Most likely. Applications of AI such as predictive analytics are already decreasing costs and improving reliability of industrial machinery. Furthermore, the funding and research going into AI now comes from a wide range of com...
SYS-CON Events announced today that GrapeUp, the leading provider of rapid product development at the speed of business, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company, specialized in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market acr...
In this presentation, Striim CTO and founder Steve Wilkes will discuss practical strategies for counteracting fraud and cyberattacks by leveraging real-time streaming analytics. In his session at @ThingsExpo, Steve Wilkes, Founder and Chief Technology Officer at Striim, will provide a detailed look into leveraging streaming data management to correlate events in real time, and identify potential breaches across IoT and non-IoT systems throughout the enterprise. Strategies for processing massive ...
SYS-CON Events announced today that Ayehu will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on October 31 - November 2, 2017 at the Santa Clara Convention Center in Santa Clara California. Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infras...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex software systems for startups and enterprises. Since 2009 it has grown from a small group of passionate engineers and business...
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
What's the role of an IT self-service portal when you get to continuous delivery and Infrastructure as Code? This general session showed how to create the continuous delivery culture and eight accelerators for leading the change. Don Demcsak is a DevOps and Cloud Native Modernization Principal for Dell EMC based out of New Jersey. He is a former, long time, Microsoft Most Valuable Professional, specializing in building and architecting Application Delivery Pipelines for hybrid legacy, and cloud ...